NFKB1 and inflammatory bowel disease: Mice with experimentally induced colitis that were given methionine-restricted diets showed significant suppression of NF-kB activation, consistent with those in human patients with IBD and suggesting that methionine restriction could be used as an immunomodulator and anti-inflammatory modulator in IBD patients [51].